Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 152 | 151 | 153 | 149 | 151 |
| Accounts receivable | -145 | 165 | -207 | 95 | -112 |
| Other Working Capital | 666 | -419 | -710 | 94 | -263 |
| Other Operating Activity | -1,701 | -1,831 | -1,084 | -2,512 | -434 |
| Operating Cash Flow | $-1,029 | $-1,934 | $-1,848 | $-2,174 | $-658 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | N/A | N/A | -34 |
| Purchase Of Investment | 0 | -21 | 0 | -21 | N/A |
| Sale Of Investment | 0 | 21 | 0 | 21 | N/A |
| Other Investing Activity | 0 | 0 | -9 | 0 | 0 |
| Investing Cash Flow | $0 | $0 | $-9 | $0 | $-34 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 4,654 | 0 | 0 |
| Financing Cash Flow | $0 | $0 | $4,654 | $0 | $0 |
| Beginning Cash Position | 7,601 | 9,535 | 6,738 | 8,913 | 9,604 |
| End Cash Position | 6,572 | 7,601 | 9,535 | 6,738 | 8,913 |
| Net Cash Flow | $-1,029 | $-1,934 | $2,797 | $-2,174 | $-692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,029 | -1,934 | -1,848 | -2,174 | -658 |
| Capital Expenditure | N/A | 0 | N/A | N/A | -34 |
| Free Cash Flow | -1,029 | -1,934 | -1,848 | -2,174 | -692 |